# GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study

Study · id `cardio:ct-nct07166133` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07166133](<https://clinicaltrials.gov/study/NCT07166133>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07166133

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 125 participants.

## Technical summary

Registry record NCT07166133. Allocation not applicable; no masking; primary purpose treatment. Start 2026-03-02 (actual); primary completion 2028-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 125 participants (planned count; ClinicalTrials.gov record NCT07166133, source copy `cardio:ctgov-nct07166133-2026-11-12`, retrieved 2026-11-18)
- Started: 2026-03-02 (actual) (ClinicalTrials.gov record NCT07166133, source copy `cardio:ctgov-nct07166133-2026-11-12`, retrieved 2026-11-18)
- Primary completion: 2028-07 (anticipated) (ClinicalTrials.gov record NCT07166133, source copy `cardio:ctgov-nct07166133-2026-11-12`, retrieved 2026-11-18)
- Completion: 2036-03 (anticipated) (ClinicalTrials.gov record NCT07166133, source copy `cardio:ctgov-nct07166133-2026-11-12`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT07166133, source copy `cardio:ctgov-nct07166133-2026-11-12`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07166133-2026-11-12`, retrieved 2026-11-18)

## The registry's words

- Brief title: GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
- Condition: Aortic Arch Dissection
- Condition: Aortic Arch Aneurysm
- Intervention (Device): GORE® TAG® Thoracic Branch Endoprosthesis
- Lead sponsor: W.L.Gore & Associates
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic aneurysm (`cardio:aortic-aneurysm`)
- Registry condition terms include this condition: Aortic dissection (`cardio:aortic-dissection`)
- Registry condition terms include this condition: Thoracic aortic aneurysm (`cardio:thoracic-aortic-aneurysm`)
- Registry lists this organization as the lead sponsor: W.L.Gore & Associates (`cardio:org-w-l-gore-associates`)

## Provenance

Content hash: e4117892e79bca479e4e56ba8c7387c17b5a9a6604f74a51b17efabdf997d229
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
